These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6176685)

  • 1. In vivo biosynthesis of 35S-substance P from [35S]methionine in the rat striatum and its transport to the substantia nigra.
    Torrens Y; Michelot R; Beaujouan JC; Glowinski J; Bockaert J
    J Neurochem; 1982 Jun; 38(6):1728-34. PubMed ID: 6176685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo biosynthesis of [35S]- and [3H]substance P in the striatum of the rat and their axonal transport to the substantia nigra.
    Krause JE; Reiner AJ; Advis JP; McKelvy JF
    J Neurosci; 1984 Mar; 4(3):775-85. PubMed ID: 6200582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axonal transport of proteins and glycoproteins in the rat nigro-striatal pathway and the effects of 6-hydroxydopamine.
    Roger LJ; Breese GR; Morell P
    Brain Res; 1980 Sep; 197(1):95-112. PubMed ID: 6156743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo synthesis of substance P in the corpus striatum of the rat and its transport to the substantia nigra.
    Sperk G; Singer EA
    Brain Res; 1982 Apr; 238(1):127-35. PubMed ID: 6177379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The striatonigral substance P pathway and dopaminergic mechanisms.
    Glowinski J; Torrens Y; Beaujouan JC
    Ciba Found Symp; 1982; (91):281-95. PubMed ID: 6183075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in substance P concentrations after protein synthesis inhibition provide an index of substance P utilization.
    Bannon MJ; Goedert M
    Brain Res; 1984 May; 301(1):184-6. PubMed ID: 6203608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dramatic increase in nigral t-[35S]butylbicyclophosphorothionate binding sites elicited by the degeneration of the striato-nigral GABAergic pathway: reversal by diazepam.
    Sanna E; Serra M; Pepitoni S; Biggio G
    Brain Res; 1989 Oct; 501(1):144-9. PubMed ID: 2553212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurokinin A and substance P in striato-nigral neurons in rat brain.
    Lindefors N; Brodin E; Ungerstedt U
    Neuropeptides; 1986; 8(2):127-32. PubMed ID: 2429229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a unilateral 6-hydroxydopamine lesion and prolonged L-3,4-dihydroxyphenylalanine treatment on peptidergic systems in rat basal ganglia.
    Taylor MD; De Ceballos ML; Rose S; Jenner P; Marsden CD
    Eur J Pharmacol; 1992 Aug; 219(2):183-92. PubMed ID: 1385171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of GABA and L-glutamic acid on the potassium-evoked in vitro release of substance P- and neurokinin A-like immunoreactivities are different in the rat striatum and substantia nigra.
    Humpel C; Saria A
    Neurosci Lett; 1989 Oct; 105(1-2):159-63. PubMed ID: 2484728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density.
    Masuo Y; Pélaprat D; Montagne MN; Scherman D; Rostène W
    Brain Res; 1990 Mar; 510(2):203-10. PubMed ID: 1970504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the origin of substance P and glutamic acid decarboxylase (GAD) in the substantia nigra.
    Brownstein MJ; Mroz EA; Tappaz ML; Leeman SE
    Brain Res; 1977 Oct; 135(2):315-23. PubMed ID: 922480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposite responses in the striato-nigral substance P system to D1 and D2 receptor activation.
    Sonsalla PK; Gibb JW; Hanson GR
    Eur J Pharmacol; 1984 Oct; 105(1-2):185-7. PubMed ID: 6208043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscarinic antagonists in substantia nigra influence the decarboxylation of L-dopa in striatum.
    Izurieta-Sánchez P; Sarre S; Ebinger G; Michotte Y
    Eur J Pharmacol; 2000 Jul; 399(2-3):151-60. PubMed ID: 10884514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D1 dopamine receptor-mediated substance P depletion in the striatonigral neurons of rats subjected to neonatal dopaminergic denervation: implications for self-injurious behavior.
    Sivam SP
    Brain Res; 1989 Oct; 500(1-2):119-30. PubMed ID: 2481560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo release of newly synthesized [3H]GABA in the substantia nigra of the rat: relative contribution of GABA striato-pallido-nigral afferents and nigral GABA neurons.
    Lantin le Boulch N; Truong-Ngoc NA; Gauchy C; Besson MJ
    Brain Res; 1991 Sep; 559(2):200-10. PubMed ID: 1794098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective antagonists of dopamine receptor subtypes differentially affect substance P levels in the striatum and substantia nigra.
    Oblin A; Zivkovic B; Bartholini G
    Brain Res; 1987 Sep; 421(1-2):387-90. PubMed ID: 2446703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo release of substance P in the cat substantia nigra.
    Michelot R; Leviel V; Torrens Y; Glowinski J; Chéramy A
    Neurosci Lett; 1979 Dec; 15(2-3):141-6. PubMed ID: 93729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of haloperidol and clozapine on preprotachykinin-A messenger RNA, tachykinin tissue levels, release and neurokinin-1 receptors in the striato-nigral system.
    Humpel C; Knaus GA; Auer B; Knaus HG; Haring C; Theodorsson E; Saria A
    Synapse; 1990; 6(1):1-9. PubMed ID: 1697986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-methyl-D-aspartate receptor antagonism alters substance P and met5-enkephalin biosynthesis in neurons of the rat striatum.
    Somers DL; Beckstead RM
    J Pharmacol Exp Ther; 1992 Aug; 262(2):823-33. PubMed ID: 1380083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.